Patent Assignment
Reel/Frame 042562/0957
Court Order
Recorded: 2017-06-01
Pages: 14
Assignor
NUCLEA BIOTECHNOLOGIES, INC.
Executed: 2017-03-29
Assignee
NMDX, LLC
105 ELM STREET, PITTSFIELD, MASSACHUSETTS, 01201
Covered Properties
(37)
Detachable Base Assembly for Dual Oriented Computer System Unit
Patent:
330,021 →
Application:
07/471,987 →
Frozen Tissue Microarrayer
Patent:
6,534,307 →
Application:
09/779,753 →
Method of Making Frozen Tissue Microarrays
Kinase Peptides and Antibodies
Gene and Protein Expression Profiles Associated with the Therapeutic Efficacy of Irinotecan
Gene and Protein Expression Profiles Associated with the Therapeutic Efficacy of Egfr-Tk Inhibitors
Gene and Protein Expression Profiles Associated with the Therapeutic Efficacy of Egfr-Tk Inhibitors
Gene and Protein Expression Profiles Associated with the Therapeutic Efficacy of Irinotecan
Anti-Phospho-Akt Antibodies
Biomarker Panel For Prediction Of Recurrent Colorectal Cancer
Application:
12/936,231 →
Publication:
US 2011/0059464
Antibodies Against Fatty Acid Synthase
Biomarkers for Prediction of Breast Cancer
Application:
13/303,603 →
Publication:
US 2012/0149594
Gene and Protein Expression Profiles Associated with the Therapeutic Efficacy of Egfr-Tk Inhibitors
Method and Assay for Determining Fas Expression
Predictive Biomarkers for Breast Cancer
Application:
13/651,588 →
Publication:
US 2013/0095483
USP2A Peptides and Antibodies
USP2A Peptides and Antibodies
Application:
13/895,393 →
Publication:
US 2013/0237691
USP2A Peptides and Antibodies
Application:
13/895,399 →
Publication:
US 2013/0303744
USP2A Peptides and Antibodies
Application:
13/895,405 →
Publication:
US 2013/0237449
Predictive Markers For Cancer and Metabolic Syndrome
Application:
13/916,635 →
Publication:
US 2013/0338027
Gene Expression Profile for Therapeutic Response to Vegf Inhibitors
Application:
14/110,456 →
Publication:
US 2014/0080737
Predictive Biomarkers for Prostate Cancer
Application:
14/115,430 →
Publication:
US 2014/0127708
Method and Assay for Determining Fas Expression
Application:
14/150,007 →
Publication:
US 2014/0127714
Antibodies Against Fatty Acid Synthase
Mixed Format Microarrays
Application:
14/302,847 →
Publication:
US 2014/0371087
Congestive Heart Failure Biomarkers
Application:
14/366,194 →
Publication:
US 2014/0364334
Mrm-Ms Signature Assay
Application:
14/398,794 →
Publication:
US 2015/0133342
Predictive Biomarkers for Breast Cancer
Application:
14/516,844 →
Publication:
US 2015/0050665
Anti-Phospho-Akt Antibodies
USP2A Peptides and Antibodies
Application:
14/689,797 →
Publication:
US 2015/0218290
Biomarker Panel for Prediction of Recurrent Colon Cancer
Application:
14/796,083 →
Publication:
US 2015/0309034
Msia-Srm Assay for Biomarker Analysis
Application:
14/913,476 →
Publication:
US 2016/0209412
Predictive Biomarkers for Metabolic Syndrome
Application:
15/047,779 →
New Stylet
Patent:
473,648 →
Application:
29/131,964 →
Stylet
Patent:
598,548 →
Application:
29/272,791 →
Beam Dump Assembly
Patent:
714,959 →
Application:
29/436,506 →
Lens Mount
Patent:
718,800 →
Application:
29/437,175 →
Related Assignments
(17)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 13, 2005
From: CLINOMICS BIOSCIENCES, INC.
To: LAURUS MASTER FUND, LTD.
Reel/Frame 016446/0103 →
Assignment of Assignor's Interest
Apr 7, 2008
From: MURACA, PATRICK J.
To: NUCLEA BIOMARKERS, LLC
Reel/Frame 020815/0575 →
Assignment of Assignor's Interest
Jul 6, 2009
From: MURACA, PATRICK J.
To: NUCLEA BIOMARKERS, LLC
Reel/Frame 022914/0618 →
Assignment of Assignor's Interest
Dec 23, 2009
From: MURACA, PATRICK J
To: NUCLEA BIOMARKERS, LLC
Reel/Frame 023701/0317 →
Assignment of Assignor's Interest
Oct 13, 2011
From: MURACA, PATRICK J.
To: NUCLEA BIOTECHNOLOGIES, INC.
Reel/Frame 027053/0199 →
Assignment of Assignor's Interest
Jan 10, 2012
From: MURACA, PATRICK J.
To: NUCLEA BIOTECHNOLOGIES, INC.
Reel/Frame 027507/0626 →
Assignment of Assignor's Interest
Jan 30, 2012
From: MURACA, PATRICK J.
To: NUCLEA BIOTECHNOLOGIES, INC.
Reel/Frame 027618/0286 →
Assignment of Assignor's Interest
Jan 31, 2012
From: MURACA, PATRICK J.
To: NUCLEA BIOTECHNOLOGIES, INC.
Reel/Frame 027625/0439 →
Assignment of Assignor's Interest
Jul 17, 2012
From: LAURUS MASTER FUND, LTD.
To: NUCLEA BIOTECHNOLOGIES, INC.
Reel/Frame 028563/0231 →
Assignment of Assignor's Interest
Jul 19, 2012
From: MURACA, PATRICK J.
To: NUCLEA BIOTECHNOLOGIES, INC.
Reel/Frame 028585/0393 →
Assignment of Assignor's Interest
Nov 20, 2012
From: MURACA, PATRICK J.
To: NUCLEA BIOTECHNOLOGIES, INC.
Reel/Frame 029327/0407 →
Assignment of Assignor's Interest
Nov 20, 2012
From: MURACA, PATRICK J.
To: NUCLEA BIOTECHNOLOGIES, INC.
Reel/Frame 029327/0298 →
Assignment of Assignor's Interest
Jun 14, 2013
From: MURACA, PATRICK J.
To: NUCLEA BIOTECHNOLOGIES, INC.
Reel/Frame 030615/0931 →
Assignment of Assignor's Interest
Jun 14, 2013
From: MURACA, PATRICK J.
To: NUCLEA BIOTECHNOLOGIES, INC.
Reel/Frame 030615/0759 →
Assignment of Assignor's Interest
Jun 14, 2013
From: MURACA, PATRICK J
To: NUCLEA BIOTECHNOLOGIES, INC.
Reel/Frame 030615/0893 →
Assignment of Assignor's Interest
Jun 26, 2013
From: MURACA, PATRICK J.
To: NUCLEA BIOTECHNOLOGIES, INC.
Reel/Frame 030686/0326 →
Assignment of Assignor's Interest
Jul 10, 2015
From: NUCLEA BIOMARKERS LLC
To: NUCLEA BIOTECHNOLOGIES, INC.
Reel/Frame 036056/0049 →